Can Duvelisib and Eganelisib work for both cancer and COVID-19? Molecular-level insights from MD simulations and enhanced samplings

SK Panda, S Karmakar, PSS Gupta… - Physical Chemistry …, 2024 - pubs.rsc.org
SARS-CoV-2 has caused severe illness and anxiety worldwide, evolving into more dreadful
variants capable of evading the host's immunity. Cytokine storms, led by PI3Kγ, are common …

[HTML][HTML] Ciclesonide Inhibits SARS-CoV-2 Papain-Like Protease in Vitro

Y Kiba, T Tanikawa, M Kitamura - Biological and Pharmaceutical …, 2024 - jstage.jst.go.jp
The emergence of coronavirus disease 2019 (COVID-19), a novel identified pneumonia
resulting from the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus, has …